
News
from the fight to #SaveIndiePharmacy
New York Times’ The Middlemen series

Congress targets PBMs to curb drug prices, end spread pricing practices
The House is renewing a push to take on pharmacy benefit managers that play an important role in the cost of prescription drugs that has been heavily scrutinized by lawmakers amid industry consolidation and rising prices.
Drugmakers including Purdue Pharma paid pharmacy benefit managers not to restrict painkiller prescriptions, a New York Times investigation found.